Skip to content

Operating margin at other companies

Avanos Medical logo
Avanos MedicalAVNS
-9.1%-4.2pp
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
23.7%+2.3pp
AtriCure logo
AtriCureATRC
-5.1%-1.3pp

Other financials

Income statement

See full
Revenue$177.4M+5.0%
Gross profit$141.0M+4.7%
Operating income$6.9M+247%
Net income$2.9M-39.4%
EPS (diluted)$0.07-30.0%

Balance sheet

See full
Cash & equivalents$144.3M-49.1%
Total debt$411.2M+15.3%
Total equity$653.9M-18.1%
Total assets$1.2B-23.8%

Cash flow

See full
Operating cash flow$25.7M-27.6%
CapEx$2.7M-68.1%
Free cash flow$23.0M-14.7%

Valuation

See full
Market cap$942.78M-16.0%
Enterprise value$1.21B+1.2%
P/E183.5×
P/S1.3×-0.3×

Profitability

See full
Gross margin79.3%+1.7pp
Net margin0.7%
FCF margin18.1%-4.6pp

Returns & leverage

See full
Return on equity0.7%
Debt / equity0.6×+0.2×
Current ratio4.7×+2.3×

Where this comes from

Calculated from Pacira BioSciences, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacira BioSciences, Inc.'s operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pacira BioSciences, Inc.'s operating margin?
Pacira BioSciences, Inc. (PCRX) reported operating margin of 3.3% in Q1 2026.
What is the long-term trend for Pacira BioSciences, Inc.'s operating margin?
Over 3 years (2020 to 2025), Pacira BioSciences, Inc.'s operating margin has grown at a -37.4% compound annual growth rate (CAGR), from 10.8% to 2.6%.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.